S90652 in Paediatric Hypertension

Phase 2

Completed

• Conditions: Hypertension

• Registration Number: NCT00202592
• Lead Sponsor: Institut de Recherches Internationales Servier

Brief Summary

The aim of the study is to assess the long-term safety and effects on blood pressure of a paediatric formulation of perindopril in hypertensive children

Detailed Description

Not available

Study Timeline

• Study Start: 2003-11
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-12
• Study First Posted: 2005-09-20
• Primary Completion: 2010-04
• Study Completion: 2010-04
• Status Verified: 2018-04
• Last Update Submitted: 2018-04-10
• Last Update Posted: 2018-04-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Hypertensive children, who have been treated for four months at least with S90652, with safety and efficacy

Exclusion Criteria

• Poorly controlled hypertension
• Girls with signs of pubescence

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Clinical safety assessed from the patient's (parents) complaints and clinical follow-up

Secondary Outcome Measures

Name	Time	Method
Blood pressure

Trial Locations

Locations (1)

Hôpital Necker Enfants Malades; 🇫🇷 Paris, France